TANYA ZARKHINA: Open Payments
NPI 1710602552 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,410 in 36 payments from 14 companies in 2025. Trend: 2023 $2,802 · 2024 $1,515 · 2025 $1,410
Food & beverage: $1,410
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $563 |
| Kowa Pharmaceuticals America, Inc. | 5 | $225 |
| Verona Pharma, Inc. | 1 | $145 |
| Ardelyx, Inc. | 3 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $87 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| Amgen Inc. | 2 | $43 |
| SCILEX PHARMACEUTICALS INC. | 2 | $43 |
| Novo Nordisk Inc | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
Products named: ZORYVE, QULIPTA, CREON, Ohtuvayre, UBRELVY, IBSRELA, JARDIANCE, XIFAXAN.
Industry payments across NY — which companies pay providers there.
